Video interview – Nick Hartshorne-Evans
As part of the roundtable debate on secondary prevention of recurrent atherothrombotic events, Dr Paul Tunnah speaks with a participant, expert patient Nick Hartshorne-Evans, to hear his perspectives on secondary prevention.
This media accompanies the roundtable video debate ‘Secondary prevention of recurrent atherothrombotic events among high-risk patients’, sponsored by AstraZeneca.
In conjunction with the roundtable video debate, pharmaphorum are releasing individual video interviews with the four expert participants. Here, Nick Hartshorne-Evans gives his views on secondary prevention and the patient role in improvement.
(Interview conducted August 2017)
Video quick links
00:12 – From a patient’s perspective, what is the awareness of the risk of secondary events?
01:38 – Based on your experience, if a patient has had a primary event, what is the right time to start talking about secondary events?
02:46 – How well do you think patients appreciate clinical guidelines around secondary prevention?
03:57 – How do we balance guidelines for the overall patient population with the individual patient and their own specific needs?
05:24 – How can patient groups make sure the patient voice is represented at the government level?
06:42 – How do you make sure patients understand the advice and get feedback, or validation, on how it’s working?
08:37 – Where do you see disruption coming from in the context of secondary prevention?
09:55 – If you could change one thing in terms of how we manage secondary prevention now, what would it be?
For further materials relating to this roundtable debate, please visit the spotlight page.